Evidence map›Paper›PMID 37632837›Full record

ArticleProtein science : a publication of the Protein Society2023

De novo design of monomeric helical bundles for pH-controlled membrane lysis.

Nicolas Goldbach, Issa Benna, Basile I M Wicky, Jacob T Croft, Lauren Carter, Asim K Bera, Hannah Nguyen, Alex Kang, Banumathi Sankaran, Erin C Yang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. De novo design of monomeric helical bundles for pH-controlled membrane lysis.Protein science : a publication of the Protein Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Nicolas GoldbachInstitute for Protein Design, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-5401-3892
Issa BennaInstitute for Protein Design, University of Washington, Seattle, Washington, USA.
Basile I M WickyInstitute for Protein Design, University of Washington, Seattle, Washington, USA.
Jacob T CroftDepartment of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.
Lauren CarterInstitute for Protein Design, University of Washington, Seattle, Washington, USA.
Asim K BeraInstitute for Protein Design, University of Washington, Seattle, Washington, USA.
Hannah NguyenInstitute for Protein Design, University of Washington, Seattle, Washington, USA.
Alex KangInstitute for Protein Design, University of Washington, Seattle, Washington, USA.
Banumathi SankaranMolecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
Erin C YangInstitute for Protein Design, University of Washington, Seattle, Washington, USA.
Kelly K LeeDepartment of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.
David BakerInstitute for Protein Design, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-7896-6217
University of Washington · USHoward Hughes Medical Institute · USLawrence Berkeley National Laboratory · US

Funding

Lipid Bilayer Remodeling and Protein Intermediates During Membrane FusionR01AI165808 · NIAID · UNIVERSITY OF WASHINGTON · PI LEE, KELLY KEISEN · 2022 to 2025
$2.4M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI165808
6 · The paper itself

Abstract

Targeted intracellular delivery via receptor-mediated endocytosis requires the delivered cargo to escape the endosome to prevent lysosomal degradation. This can in principle be achieved by membrane lysis tightly restricted to endosomal membranes upon internalization to avoid general membrane insertion and lysis. Here, we describe the design of small monomeric proteins with buried histidine containing pH-responsive hydrogen bond networks and membrane permeating amphipathic helices. Of the 30 designs that were experimentally tested, all expressed in Escherichia coli, 13 were monomeric with the expected secondary structure, and 4 designs disrupted artificial liposomes in a pH-dependent manner. Mutational analysis showed that the buried histidine hydrogen bond networks mediate pH-responsiveness and control lysis of model membranes within a very narrow range of pH (6.0-5.5) with almost no lysis occurring at neutral pH. These tightly controlled lytic monomers could help mediate endosomal escape in designed targeted delivery platforms.

Indexed as

HistidineLiposomesHydrogen-Ion ConcentrationProtein Structure, SecondaryHistidineLiposomescoiled-coilendosomal escapemembrane disruptionpH responsiveprotein design

Identifiers

PMID37632837
PMCPMC10578055
OpenAlexW4386189082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.